Angiotensin II (Ang-II) stimulates vascular inflammation, oxidative stress, and formation and rupture of intracranial aneurysms in mice. Because angiotensin 1-7 (Ang-1-7) acts on Mas receptors and generally counteracts deleterious effects of Ang-II, we tested the hypothesis that Ang-1-7 attenuates formation and rupture of intracranial aneurysms. Intracranial aneurysms were induced in wild type and Mas receptor deficient mice using a combination of Ang-II-induced hypertension and intracranial injection of elastase in the basal cistern. Mice received elastase+Ang-II alone, or a combination of elastase+Ang-II+Ang-1-7. Aneurysm formation, prevalence of subarachnoid hemorrhage, mortality, and expression of molecules involved in vascular injury were assessed. Systolic blood pressure was similar in mice receiving elastase+Ang-II (148±5 mmHg, mean ±SE) or elastase+Ang-II+Ang-1-7 (144±5 mmHg). Aneurysm formation was also similar in mice receiving elastase+Ang-II (89%) or elastase+Ang-II+Ang-1-7 (84%). However, in mice that received elastase and Ang II, Ang-1-7 reduced mortality (from 64 to 36%, p<0.05) and prevalence of subarachnoid hemorrhage (from 75 to 48%, p<0.05). In cerebral arteries, expression of the inflammatory markers, Nox2 and catalase increased similarly in elastase+Ang-II or elastase+Ang-II+Ang-1-7 groups. Ang-1-7 increased expression of cyclooxygenase-2, and decreased expression of metalloproteinase 9 induced by elastase+Ang-II (p<0.05). In Mas receptor deficient mice, systolic blood pressure, mortality, and prevalence of subarachnoid hemorrhage were similar (p>0.05) in groups treated with elastase+Ang-II or elastase+Ang-II+Ang-1-7. Expression of Mas receptor was detected by immunohistochemistry in samples of human intracranial arteries and aneurysms. In conclusion, without attenuating Ang-II-induced hypertension, Ang-1-7 decreased mortality and rupture of intracranial aneurysms in mice, through a Mas receptor-dependent pathway.